Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a non-coding RNA gene identified in the human genome as an antisense transcript to the protein-coding gene **Mediator complex subunit 26 (MED26)**. It does not encode a protein and its biological function has not been established in scientific literature. Antisense transcripts can sometimes modulate the expression of their corresponding sense genes, but there is currently no validated functional or disease role for "Novel transcript, antisense to MED26". It is not considered an actionable therapeutic target or drug-interacting molecule in current biomedical or pharmacological knowledge. If you seek information on the **MED26 protein**, that target is well characterized as a transcription coactivator and subunit of the Mediator complex, which governs transcriptional regulation mechanisms. However, the "novel transcript, antisense to MED26" (LOC105372295) is a non-coding RNA with unestablished functional significance.
*None reported*. Non-coding antisense RNAs sometimes regulate overlapping coding genes (here, potentially MED26), but no actionable mechanism is established for this transcript
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Mediator complex subunit 26 (LOC105372295).